Harris Rotman - Net Worth and Insider Trading
Harris Rotman Net Worth
The estimated net worth of Harris Rotman is at least $1 Million dollars as of 2024-12-26. Harris Rotman is the SVP Regulatory Affairs of Centessa Pharmaceuticals PLC and owns about 62,625 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $1 Million. Details can be seen in Harris Rotman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harris Rotman has not made any transactions after 2024-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Harris Rotman
Harris Rotman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harris Rotman owns 1 companies in total, including Centessa Pharmaceuticals PLC (CNTA) .
Click here to see the complete history of Harris Rotman’s form 4 insider trades.
Insider Ownership Summary of Harris Rotman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2024-02-01 | SVP Regulatory Affairs |
Harris Rotman Latest Holdings Summary
Harris Rotman currently owns a total of 1 stock. Harris Rotman owns 62,625 shares of Centessa Pharmaceuticals PLC (CNTA) as of February 1, 2024, with a value of $1 Million.
Latest Holdings of Harris Rotman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2024-02-01 | 62,625 | 16.90 | 1,058,363 |
Holding Weightings of Harris Rotman
Harris Rotman Form 4 Trading Tracker
According to the SEC Form 4 filings, Harris Rotman has made a total of 2 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the sale of 4,267 shares on February 1, 2024, which brought Harris Rotman around $34,563.
Insider Trading History of Harris Rotman
- 1
Harris Rotman Trading Performance
Harris Rotman Ownership Network
Harris Rotman Owned Company Details
What does Centessa Pharmaceuticals PLC do?
Who are the key executives at Centessa Pharmaceuticals PLC?
Harris Rotman is the SVP Regulatory Affairs of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include director & Chief Executive Officer Saurabh Saha , Chief People Officer Karen M. Anderson , and Chief Quality Officer Tia L Bush .
Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary
Over the past 18 months, Harris Rotman made 2 insider transaction in Centessa Pharmaceuticals PLC (CNTA) with a net sale of 41,751. Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 575,000 shares made by Saurabh Saha , a net sale of 123,361 shares made by Gregory M Weinhoff , and a net sale of 67,660 shares made by Karen M. Anderson .
In summary, during the past 3 months, insiders sold 433,371 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 433,371 shares. During the past 18 months, 912,901 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 912,901 shares.
Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Centessa Pharmaceuticals PLC Insider Transactions
Harris Rotman Mailing Address
Above is the net worth, insider trading, and ownership report for Harris Rotman. You might contact Harris Rotman via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Fl., 1 Ashley Rd, Altrincham, Cheshire X0 Wa14 2dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
